The object of the contract consists in the supply of various medicinal products (dispensing to out-of-hospital patients), oral forms. The description of the supplies requested shall be included in the procurement documents. The establishments which will be parties to the contracts to be concluded at the end of the procedure are: - the Centre hospitalier Émile Mayrisch (CHEM), - the Centre hospitalier de Luxembourg (CHL), - the Centre hospitalier du Nord (CHdN), and - the Robert Schuman Hospitals (HRS).

Abemaciclib, oral forms, 50 mg, 100 mg and 150 mg.

Dabrafenib, oral form, 75 mg.

Fingolimod, oral form, 0.5 mg.

Ribociclib, oral form, 200 mg.

Trametinib, oral form, 2 mg.

Macitentan, oral form, 10 mg.